Dividend2 May 2026, 04:30 pm
Epigral Recommends Final Dividend of ₹5.00 for FY26
AI Summary
The Board of Directors of Epigral Ltd recommended a final dividend of ₹5.00 (50.00%) per equity share with a face value of ₹10 each for the financial year 2025-26. This decision was made during the board meeting held on May 2, 2026, where the audited financial results for the fourth quarter and year ended March 31, 2026, were also approved.
Key Highlights
- Epigral Ltd recommends a final dividend of ₹5.00 per share for FY26.
- The dividend is 50% on the equity share face value of ₹10.
- Board approved audited financial results for Q4 and FY26.
- M/s. S R B C & CO LLP issued an unmodified audit opinion.
Price Impact
More from MFL